Arrowhead Pharmaceuticals
ARWR
#2055
Rank
C$13.21 B
Marketcap
C$94.38
Share price
0.30%
Change (1 day)
222.58%
Change (1 year)

Operating Margin for Arrowhead Pharmaceuticals (ARWR)

Operating Margin as of February 2026 (TTM): 6.21%

According to Arrowhead Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 6.21%. At the end of 2025 the company had an Operating Margin of 6.21%.

Operating Margin history for Arrowhead Pharmaceuticals from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
20256.21%-100.04%
2024-17,247.54%20007.83%
2023-85.78%20.8%
2022-71.01%-30.28%
2021-101.85%6%
2020-96.09%-338%
201940.37%-111.97%
2018-337.30%208.16%
2017-109.46%-99.79%
2016-51,613.12%114.45%
2015-24,067.67%-28.27%
2014-33,554.35%207.22%
2013-10,922.08%-27.45%
2012-15,054.05%407.47%
2011-2,966.52%
2009-520.47%-80.62%
2008-2,685.89%-14.5%
2007-3,141.43%-8.68%
2006-3,439.94%111.82%
2005-1,624.03%27.72%
2004-1,271.56%
2002-10,865.27%444.49%
2001-1,995.50%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
18.78% 202.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-142.82%-2,399.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
1.50%-75.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-61.01%-1,082.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
-16.78%-370.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-49,254.30%-793,244.93%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.